Halozyme Therapeutics, Inc. announced the appointment of David Ramsay as Interim Chief Financial Officer, effective March 23, 2026. Ramsay brings over 30 years of financial leadership experience, previously serving as CFO of Halozyme from 2003 to 2009 and 2013 to 2015.

Press Release distribution

National Press Distribution across U.S. Media. Direct Access to Key Decision Making Editors.